Appyea Inc (APYP)

[linkvest]

RIGHT FROM SLEEPX PAGE:

02/23/2021
Paid 60% of the payment for the University's Patent License Agreement.

Examines an engagement with a leading law firm specializing in patent litigation and intellectual property protection. Vew our IP portfolio

02/18/2021
DONE!
Advancing to next stage! Click to see the public disclosure

01/31/2021
Following the public disclosure of the LOI amongst our companies and APPYA Inc. (OTCPINK: APYP),
we are pleased to announce that we have reached preliminary understandings on the principal terms of the acquisition and are working towards it.

We believe that the acquisition should provide significant value for all parties and allow the DreamIT X3, our principal anti-snoring product, to reach the market as early as the first half of 2022 under the “Wellness Gadgets” category, which will allow for a shorter time for the market.

We believe that there is a pressing need for the device. According to the American National Sleep Foundation in the United States, 57% of men and 40% of women suffer from chronic snoring https://www.sleepfoundation.org/snoring



DreamIT X3 is based on a unique technology that is patents protected and is a revolutionary solution to snoring. We believe per unit retael price should not exced $149.



We are excited to begin working with our US strategic partners to realize our business vision!